Pure Global

Clinical Trial - Trial ChiCTR2100050024

Access comprehensive clinical trial information for ChiCTR2100050024 through Pure Global AI's free database. This Phase 1 trial is sponsored by Hunan Provincial Center for Disease Control and Prevention and is currently Not yet recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100050024
Phase 1
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100050024
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
A randomized, double blind, placebo controlled phase I clinical trial to evaluate the safety and immunogenicity of the Novel Coronavirus inactivated vaccine (Vero cells) in healthy individuals 18 years of age and older

Study Focus

Sponsor & Location

Hunan Provincial Center for Disease Control and Prevention

Ningbo Rong an Biological pharmaceutical Co., LTD

China

Timeline & Enrollment

Phase 1

N/A

Apr 30, 2023

ICD-10 Classifications

COVID-19, virus identified
Viral pneumonia, unspecified
Other viral pneumonia
COVID-19, virus not identified
Pneumonia in viral diseases classified elsewhere

Data Source

Chinese Clinical Trial Registry

ChiCTR2100050024

Non-Device Trial